LEILANI LIM: Open Payments
NPI 1316468226 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,847 in 229 payments from 27 companies in 2025. Trend: 2023 $3,797 · 2024 $4,692 · 2025 $4,847
Food & beverage: $4,847
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 31 | $805 |
| ABBVIE INC. | 31 | $493 |
| PFIZER INC. | 26 | $376 |
| Eisai Inc. | 16 | $313 |
| Biogen, Inc. | 12 | $268 |
| SK Life Science, Inc. | 8 | $246 |
| Axsome Therapeutics, Inc. | 7 | $238 |
| CATALYST PHARMACEUTICALS, INC. | 14 | $229 |
| Teva Pharmaceuticals USA, Inc. | 6 | $207 |
| Aucta Pharmaceuticals, Inc. | 18 | $196 |
Products named: LEQEMBI, NURTEC ODT, Fintepla, Symbravo, FYCOMPA, QULIPTA, AUSTEDO XR, Motpoly XR.
Industry payments across FL — which companies pay providers there.
